Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Classical hematology 1

Conditions

Neoplasms 3Venous Thrombosis 1Venous Thromboembolism 1Thromboembolism 1Pulmonary Embolism 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

apixaban 11Dalteparin 10Rivaroxaban 7Enoxaparin 5Fondaparinux 4Tinzaparin 3Heparin, Low-Molecular-Weight 3Aspirin 3edoxaban 2Warfarin 2Observation 2Dabigatran 2sotorasib 1calcium heparin 1betrixaban 1bemiparin 1argatroban 1Tacrolimus 1Tablets 1Simvastatin 1Rosuvastatin Calcium 1Nadroparin 1Heparin 1Gemcitabine 1Drug Therapy 1Data Collection 1Cyclosporine 1AVE 5026 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Venous Thromboembolism × Nadroparin × Clear all
NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡